Neurologic manifestations of the antiphospholipid syndrome

Curr Rheumatol Rep. 2001 Aug;3(4):286-92. doi: 10.1007/s11926-001-0032-3.

Abstract

Neurologic disorders are among the most prominent clinical manifestations associated with the antiphospholipid syndrome. Such neurologic disorders are predominantly related to focal central nervous system thrombo-occlusive events. This review summarizes the latest data regarding the clinical aspects of stroke and other neurologic manifestations associated with antiphospholipid antibodies.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / etiology
  • Antibodies, Antiphospholipid / analysis*
  • Antiphospholipid Syndrome / complications
  • Antiphospholipid Syndrome / diagnosis*
  • Brain Ischemia / diagnosis
  • Brain Ischemia / etiology
  • Brain Ischemia / immunology
  • Central Nervous System Diseases / diagnosis
  • Central Nervous System Diseases / etiology*
  • Central Nervous System Diseases / immunology
  • Cerebrovascular Disorders / diagnosis
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / immunology
  • Child
  • Chorea / diagnosis
  • Chorea / etiology
  • Chorea / immunology
  • Dementia / diagnosis
  • Dementia / etiology
  • Dementia / immunology
  • Female
  • Guillain-Barre Syndrome / diagnosis
  • Guillain-Barre Syndrome / etiology
  • Guillain-Barre Syndrome / immunology
  • Humans
  • Intracranial Thrombosis / diagnosis
  • Intracranial Thrombosis / etiology
  • Intracranial Thrombosis / immunology
  • Ischemic Attack, Transient / diagnosis
  • Ischemic Attack, Transient / etiology
  • Ischemic Attack, Transient / immunology
  • Male
  • Middle Aged
  • Migraine Disorders / diagnosis
  • Migraine Disorders / etiology
  • Migraine Disorders / immunology
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / etiology
  • Multiple Sclerosis / immunology
  • Risk Factors

Substances

  • Antibodies, Antiphospholipid